pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·9h ago·1 min read
save

BioSpace podcast highlights Q3 job market gains and sharp layoff decline for biopharma talent

Oct 20, 2026·read at BioSpace ↗Positive

BioSpace Vice President of Marketing Chantal Dresner and content manager Angela Gabriel released a bonus podcast episode reviewing the biopharma job market in the third quarter of 2026.

They reported an uptick in job postings on the BioSpace platform and a dramatic drop in layoff activity, describing these trends as encouraging for professionals seeking new roles.

The conversation also touched on broader indicators of industry health and offered practical advice for candidates planning their job search in the fourth quarter.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Bonus: Q3 2026 Job Market Update”

read at BioSpace ↗
235 words · retrieved 8h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • just now2026 IPO stock tracker: How newly public biotechs are performingBioSpace
  • 9h agoRapport ekes out bipolar mania win as lead asset ‘just hits’ in mid-stage trialBioSpace
  • 9h agoEyepoint, Enlivex enact heavy layoffsBioSpace
  • 10h agoLilly puts $1.1B on the line for Hong Kong biotech’s AI drug delivery platformBioSpace
  • 11h agoGilead’s ‘highly competitive’ mid-stage ulcerative colitis data ‘validate’ I&I pushBioSpace